Loading...
Progress toward a group B streptococcal vaccine
Streptococcus agalactiae (group B Streptococcus, GBS) is a leading cause of severe invasive disease in neonate, elderly, and immunocompromised patients worldwide. Despite recent advances in the diagnosis and intrapartum antibiotic prophylaxis (IAP) of GBS infections, it remains one of the most commo...
Na minha lista:
| Udgivet i: | Hum Vaccin Immunother |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Taylor & Francis
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6314413/ https://ncbi.nlm.nih.gov/pubmed/29995578 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2018.1493326 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|